- Home
- CR vs TECH Comparison
CR vs TECH Comparison
Compare CR & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CR
- TECH
- Stock Information
- Founded
- CR 1855
- TECH 1976
- Country
- CR United States
- TECH United States
- Employees
- CR N/A
- TECH N/A
- Industry
- CR Metal Fabrications
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CR Industrials
- TECH Health Care
- Exchange
- CR Nasdaq
- TECH Nasdaq
- Market Cap
- CR 8.9B
- TECH 7.8B
- IPO Year
- CR N/A
- TECH 1989
- Fundamental
- Price
- CR $189.58
- TECH $51.96
- Analyst Decision
- CR Strong Buy
- TECH Buy
- Analyst Count
- CR 4
- TECH 11
- Target Price
- CR $197.75
- TECH $72.00
- AVG Volume (30 Days)
- CR 377.2K
- TECH 2.1M
- Earning Date
- CR 07-28-2025
- TECH 08-06-2025
- Dividend Yield
- CR 0.48%
- TECH 0.62%
- EPS Growth
- CR 54.50
- TECH N/A
- EPS
- CR 5.76
- TECH 0.83
- Revenue
- CR $2,178,600,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- CR $10.22
- TECH $7.07
- Revenue Next Year
- CR $11.07
- TECH $5.64
- P/E Ratio
- CR $33.01
- TECH $62.62
- Revenue Growth
- CR 17.22
- TECH 4.72
- 52 Week Low
- CR $127.04
- TECH $46.01
- 52 Week High
- CR $193.15
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- CR 69.38
- TECH 50.20
- Support Level
- CR $186.53
- TECH $49.27
- Resistance Level
- CR $185.81
- TECH $53.41
- Average True Range (ATR)
- CR 3.56
- TECH 1.78
- MACD
- CR 0.22
- TECH 0.13
- Stochastic Oscillator
- CR 78.20
- TECH 42.00
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.